nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.625	1	CbGbCtD
Sildenafil—Carcinoma of lung—Riluzole—amyotrophic lateral sclerosis	0.0157	0.0453	CcSEcCtD
Sildenafil—Lung neoplasm malignant—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0391	CcSEcCtD
Sildenafil—Angina unstable—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0311	CcSEcCtD
Sildenafil—Hypoaesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0301	CcSEcCtD
Sildenafil—Stridor—Riluzole—amyotrophic lateral sclerosis	0.00837	0.0241	CcSEcCtD
Sildenafil—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.00732	0.0211	CcSEcCtD
Sildenafil—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.00641	0.0185	CcSEcCtD
Sildenafil—Hernia—Riluzole—amyotrophic lateral sclerosis	0.00581	0.0167	CcSEcCtD
Sildenafil—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.00573	0.0165	CcSEcCtD
Sildenafil—Priapism—Riluzole—amyotrophic lateral sclerosis	0.00564	0.0162	CcSEcCtD
Sildenafil—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.00556	0.016	CcSEcCtD
Sildenafil—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.00492	0.0142	CcSEcCtD
Sildenafil—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00492	0.0142	CcSEcCtD
Sildenafil—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.00464	0.0134	CcSEcCtD
Sildenafil—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00434	0.0125	CcSEcCtD
Sildenafil—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.00429	0.0124	CcSEcCtD
Sildenafil—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.0042	0.0121	CcSEcCtD
Sildenafil—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00378	0.0109	CcSEcCtD
Sildenafil—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00368	0.0106	CcSEcCtD
Sildenafil—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00362	0.0104	CcSEcCtD
Sildenafil—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.0035	0.0101	CcSEcCtD
Sildenafil—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00977	CcSEcCtD
Sildenafil—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00329	0.00947	CcSEcCtD
Sildenafil—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00887	CcSEcCtD
Sildenafil—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00869	CcSEcCtD
Sildenafil—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.003	0.00863	CcSEcCtD
Sildenafil—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.003	0.00863	CcSEcCtD
Sildenafil—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00858	CcSEcCtD
Sildenafil—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00852	CcSEcCtD
Sildenafil—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00846	CcSEcCtD
Sildenafil—Gout—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00841	CcSEcCtD
Sildenafil—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00825	CcSEcCtD
Sildenafil—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00776	CcSEcCtD
Sildenafil—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00776	CcSEcCtD
Sildenafil—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00758	CcSEcCtD
Sildenafil—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00745	CcSEcCtD
Sildenafil—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00737	CcSEcCtD
Sildenafil—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00688	CcSEcCtD
Sildenafil—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00668	CcSEcCtD
Sildenafil—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00655	CcSEcCtD
Sildenafil—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00637	CcSEcCtD
Sildenafil—Injury—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0062	CcSEcCtD
Sildenafil—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00607	CcSEcCtD
Sildenafil—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00604	CcSEcCtD
Sildenafil—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00209	0.00601	CcSEcCtD
Sildenafil—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00599	CcSEcCtD
Sildenafil—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00586	CcSEcCtD
Sildenafil—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00584	CcSEcCtD
Sildenafil—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00198	0.0057	CcSEcCtD
Sildenafil—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00198	0.0057	CcSEcCtD
Sildenafil—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00561	CcSEcCtD
Sildenafil—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00191	0.0055	CcSEcCtD
Sildenafil—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00542	CcSEcCtD
Sildenafil—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00536	CcSEcCtD
Sildenafil—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00526	CcSEcCtD
Sildenafil—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00521	CcSEcCtD
Sildenafil—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00519	CcSEcCtD
Sildenafil—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00515	CcSEcCtD
Sildenafil—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00504	CcSEcCtD
Sildenafil—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00503	CcSEcCtD
Sildenafil—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00503	CcSEcCtD
Sildenafil—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00496	CcSEcCtD
Sildenafil—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00493	CcSEcCtD
Sildenafil—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00493	CcSEcCtD
Sildenafil—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00493	CcSEcCtD
Sildenafil—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00167	0.0048	CcSEcCtD
Sildenafil—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00474	CcSEcCtD
Sildenafil—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00455	CcSEcCtD
Sildenafil—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00454	CcSEcCtD
Sildenafil—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0045	CcSEcCtD
Sildenafil—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00448	CcSEcCtD
Sildenafil—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00442	CcSEcCtD
Sildenafil—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00439	CcSEcCtD
Sildenafil—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00439	CcSEcCtD
Sildenafil—Depression—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00438	CcSEcCtD
Sildenafil—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00433	CcSEcCtD
Sildenafil—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00431	CcSEcCtD
Sildenafil—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00431	CcSEcCtD
Sildenafil—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00428	CcSEcCtD
Sildenafil—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00427	CcSEcCtD
Sildenafil—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00421	CcSEcCtD
Sildenafil—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00419	CcSEcCtD
Sildenafil—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00414	CcSEcCtD
Sildenafil—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00412	CcSEcCtD
Sildenafil—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00396	CcSEcCtD
Sildenafil—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00395	CcSEcCtD
Sildenafil—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00394	CcSEcCtD
Sildenafil—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00392	CcSEcCtD
Sildenafil—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00391	CcSEcCtD
Sildenafil—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00389	CcSEcCtD
Sildenafil—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00388	CcSEcCtD
Sildenafil—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00387	CcSEcCtD
Sildenafil—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00387	CcSEcCtD
Sildenafil—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00373	CcSEcCtD
Sildenafil—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00368	CcSEcCtD
Sildenafil—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00366	CcSEcCtD
Sildenafil—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00358	CcSEcCtD
Sildenafil—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00356	CcSEcCtD
Sildenafil—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00355	CcSEcCtD
Sildenafil—Chills—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00354	CcSEcCtD
Sildenafil—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00352	CcSEcCtD
Sildenafil—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00348	CcSEcCtD
Sildenafil—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00345	CcSEcCtD
Sildenafil—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00343	CcSEcCtD
Sildenafil—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00338	CcSEcCtD
Sildenafil—Tension—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00337	CcSEcCtD
Sildenafil—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00333	CcSEcCtD
Sildenafil—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00332	CcSEcCtD
Sildenafil—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00322	CcSEcCtD
Sildenafil—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00318	CcSEcCtD
Sildenafil—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00317	CcSEcCtD
Sildenafil—Agitation—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00315	CcSEcCtD
Sildenafil—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00107	0.0031	CcSEcCtD
Sildenafil—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00308	CcSEcCtD
Sildenafil—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00308	CcSEcCtD
Sildenafil—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00307	CcSEcCtD
Sildenafil—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00303	CcSEcCtD
Sildenafil—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00302	CcSEcCtD
Sildenafil—Cough—Riluzole—amyotrophic lateral sclerosis	0.00104	0.003	CcSEcCtD
Sildenafil—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00297	CcSEcCtD
Sildenafil—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00296	CcSEcCtD
Sildenafil—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00292	CcSEcCtD
Sildenafil—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00292	CcSEcCtD
Sildenafil—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00292	CcSEcCtD
Sildenafil—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00291	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00101	0.0029	CcSEcCtD
Sildenafil—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.001	0.00289	CcSEcCtD
Sildenafil—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000992	0.00286	CcSEcCtD
Sildenafil—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000973	0.0028	CcSEcCtD
Sildenafil—Infection—Riluzole—amyotrophic lateral sclerosis	0.000966	0.00278	CcSEcCtD
Sildenafil—Shock—Riluzole—amyotrophic lateral sclerosis	0.000957	0.00276	CcSEcCtD
Sildenafil—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000954	0.00275	CcSEcCtD
Sildenafil—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000949	0.00273	CcSEcCtD
Sildenafil—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000945	0.00272	CcSEcCtD
Sildenafil—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00094	0.00271	CcSEcCtD
Sildenafil—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000927	0.00267	CcSEcCtD
Sildenafil—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000909	0.00262	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000886	0.00255	CcSEcCtD
Sildenafil—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00088	0.00253	CcSEcCtD
Sildenafil—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000873	0.00252	CcSEcCtD
Sildenafil—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000867	0.0025	CcSEcCtD
Sildenafil—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000865	0.00249	CcSEcCtD
Sildenafil—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000856	0.00247	CcSEcCtD
Sildenafil—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000846	0.00244	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00084	0.00242	CcSEcCtD
Sildenafil—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000839	0.00242	CcSEcCtD
Sildenafil—Pain—Riluzole—amyotrophic lateral sclerosis	0.000832	0.0024	CcSEcCtD
Sildenafil—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000832	0.0024	CcSEcCtD
Sildenafil—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000802	0.00231	CcSEcCtD
Sildenafil—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000795	0.00229	CcSEcCtD
Sildenafil—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000773	0.00223	CcSEcCtD
Sildenafil—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000769	0.00221	CcSEcCtD
Sildenafil—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000769	0.00221	CcSEcCtD
Sildenafil—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000717	0.00206	CcSEcCtD
Sildenafil—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000698	0.00201	CcSEcCtD
Sildenafil—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000688	0.00198	CcSEcCtD
Sildenafil—PDE6H—nervous system—amyotrophic lateral sclerosis	0.000676	0.0853	CbGeAlD
Sildenafil—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000666	0.00192	CcSEcCtD
Sildenafil—PDE6H—central nervous system—amyotrophic lateral sclerosis	0.000651	0.0822	CbGeAlD
Sildenafil—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000643	0.00185	CcSEcCtD
Sildenafil—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000618	0.00178	CcSEcCtD
Sildenafil—Rash—Riluzole—amyotrophic lateral sclerosis	0.000613	0.00177	CcSEcCtD
Sildenafil—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000613	0.00176	CcSEcCtD
Sildenafil—Headache—Riluzole—amyotrophic lateral sclerosis	0.000609	0.00175	CcSEcCtD
Sildenafil—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000578	0.00166	CcSEcCtD
Sildenafil—PDE6H—brain—amyotrophic lateral sclerosis	0.000517	0.0652	CbGeAlD
Sildenafil—ADORA2A—spinal cord—amyotrophic lateral sclerosis	0.000335	0.0423	CbGeAlD
Sildenafil—ABCC5—medulla oblongata—amyotrophic lateral sclerosis	0.000313	0.0395	CbGeAlD
Sildenafil—ADORA2A—nervous system—amyotrophic lateral sclerosis	0.000282	0.0357	CbGeAlD
Sildenafil—ADORA2A—central nervous system—amyotrophic lateral sclerosis	0.000272	0.0343	CbGeAlD
Sildenafil—ADORA2A—cerebellum—amyotrophic lateral sclerosis	0.000266	0.0335	CbGeAlD
Sildenafil—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000263	0.0332	CbGeAlD
Sildenafil—ABCC10—medulla oblongata—amyotrophic lateral sclerosis	0.000262	0.033	CbGeAlD
Sildenafil—PDE5A—nervous system—amyotrophic lateral sclerosis	0.000257	0.0325	CbGeAlD
Sildenafil—PDE5A—central nervous system—amyotrophic lateral sclerosis	0.000248	0.0313	CbGeAlD
Sildenafil—PDE5A—cerebellum—amyotrophic lateral sclerosis	0.000242	0.0306	CbGeAlD
Sildenafil—ABCC10—spinal cord—amyotrophic lateral sclerosis	0.000233	0.0295	CbGeAlD
Sildenafil—ABCC5—cerebellum—amyotrophic lateral sclerosis	0.000221	0.0279	CbGeAlD
Sildenafil—ADORA2A—brain—amyotrophic lateral sclerosis	0.000216	0.0273	CbGeAlD
Sildenafil—PDE5A—brain—amyotrophic lateral sclerosis	0.000197	0.0248	CbGeAlD
Sildenafil—ABCC10—cerebellum—amyotrophic lateral sclerosis	0.000185	0.0234	CbGeAlD
Sildenafil—ABCC5—brain—amyotrophic lateral sclerosis	0.00018	0.0227	CbGeAlD
Sildenafil—ABCC4—nervous system—amyotrophic lateral sclerosis	0.000163	0.0206	CbGeAlD
Sildenafil—ABCC4—central nervous system—amyotrophic lateral sclerosis	0.000157	0.0198	CbGeAlD
Sildenafil—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000151	0.019	CbGeAlD
Sildenafil—ABCC10—brain—amyotrophic lateral sclerosis	0.00015	0.019	CbGeAlD
Sildenafil—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000133	0.0167	CbGeAlD
Sildenafil—ABCC4—brain—amyotrophic lateral sclerosis	0.000125	0.0157	CbGeAlD
Sildenafil—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000118	0.0149	CbGeAlD
Sildenafil—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000109	0.0138	CbGeAlD
Sildenafil—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000105	0.0133	CbGeAlD
Sildenafil—CYP2E1—nervous system—amyotrophic lateral sclerosis	9.97e-05	0.0126	CbGeAlD
Sildenafil—CYP2E1—central nervous system—amyotrophic lateral sclerosis	9.6e-05	0.0121	CbGeAlD
Sildenafil—CYP2E1—cerebellum—amyotrophic lateral sclerosis	9.38e-05	0.0118	CbGeAlD
Sildenafil—CYP1A1—brain—amyotrophic lateral sclerosis	8.35e-05	0.0105	CbGeAlD
Sildenafil—CYP3A4—nervous system—amyotrophic lateral sclerosis	8.02e-05	0.0101	CbGeAlD
Sildenafil—CYP2D6—nervous system—amyotrophic lateral sclerosis	7.89e-05	0.00996	CbGeAlD
Sildenafil—CYP3A4—central nervous system—amyotrophic lateral sclerosis	7.72e-05	0.00975	CbGeAlD
Sildenafil—CYP2E1—brain—amyotrophic lateral sclerosis	7.62e-05	0.00962	CbGeAlD
Sildenafil—CYP2D6—central nervous system—amyotrophic lateral sclerosis	7.6e-05	0.00959	CbGeAlD
Sildenafil—CYP2D6—cerebellum—amyotrophic lateral sclerosis	7.43e-05	0.00937	CbGeAlD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB4—amyotrophic lateral sclerosis	6.79e-05	0.00338	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.61e-05	0.00329	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	6.6e-05	0.00329	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—RAB5A—amyotrophic lateral sclerosis	6.49e-05	0.00323	CbGpPWpGaD
Sildenafil—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.43e-05	0.0032	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—ATF1—amyotrophic lateral sclerosis	6.4e-05	0.00319	CbGpPWpGaD
Sildenafil—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.38e-05	0.00318	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—PFN1—amyotrophic lateral sclerosis	6.29e-05	0.00313	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—FIG4—amyotrophic lateral sclerosis	6.22e-05	0.0031	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	6.2e-05	0.00309	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.14e-05	0.00306	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—CASP9—amyotrophic lateral sclerosis	6.1e-05	0.00304	CbGpPWpGaD
Sildenafil—CYP2D6—brain—amyotrophic lateral sclerosis	6.03e-05	0.00761	CbGeAlD
Sildenafil—PDE6G—Disease—CST3—amyotrophic lateral sclerosis	6.03e-05	0.003	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	6.01e-05	0.00299	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	5.9e-05	0.00294	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—VCP—amyotrophic lateral sclerosis	5.88e-05	0.00293	CbGpPWpGaD
Sildenafil—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.87e-05	0.00293	CbGpPWpGaD
Sildenafil—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.82e-05	0.0029	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	5.69e-05	0.00284	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CHMP2B—amyotrophic lateral sclerosis	5.62e-05	0.0028	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—DAO—amyotrophic lateral sclerosis	5.62e-05	0.0028	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	5.62e-05	0.0028	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5.49e-05	0.00274	CbGpPWpGaD
Sildenafil—ABCC4—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	5.29e-05	0.00264	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	5.29e-05	0.00263	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	5.22e-05	0.0026	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	5.19e-05	0.00259	CbGpPWpGaD
Sildenafil—CYP3A7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.11e-05	0.00255	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	5.11e-05	0.00254	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PLB1—amyotrophic lateral sclerosis	5.09e-05	0.00253	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.06e-05	0.00252	CbGpPWpGaD
Sildenafil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	5.04e-05	0.00251	CbGpPWpGaD
Sildenafil—CYP3A7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.04e-05	0.00251	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5e-05	0.00249	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.92e-05	0.00245	CbGpPWpGaD
Sildenafil—CYP1A1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.86e-05	0.00242	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.82e-05	0.0024	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.8e-05	0.00239	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.78e-05	0.00238	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.78e-05	0.00238	CbGpPWpGaD
Sildenafil—ABCC5—Disease—VCP—amyotrophic lateral sclerosis	4.53e-05	0.00226	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.5e-05	0.00224	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.48e-05	0.00223	CbGpPWpGaD
Sildenafil—PDE6G—Disease—CASP9—amyotrophic lateral sclerosis	4.38e-05	0.00218	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PLB1—amyotrophic lateral sclerosis	4.26e-05	0.00212	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.26e-05	0.00212	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.18e-05	0.00208	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.1e-05	0.00204	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	4.09e-05	0.00204	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	4.03e-05	0.00201	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	3.98e-05	0.00198	CbGpPWpGaD
Sildenafil—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.98e-05	0.00198	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—GSR—amyotrophic lateral sclerosis	3.93e-05	0.00196	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.93e-05	0.00196	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	3.92e-05	0.00195	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	3.92e-05	0.00195	CbGpPWpGaD
Sildenafil—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	3.84e-05	0.00191	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.81e-05	0.0019	CbGpPWpGaD
Sildenafil—PDE6G—Disease—ERBB4—amyotrophic lateral sclerosis	3.75e-05	0.00187	CbGpPWpGaD
Sildenafil—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.7e-05	0.00184	CbGpPWpGaD
Sildenafil—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.69e-05	0.00184	CbGpPWpGaD
Sildenafil—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.65e-05	0.00182	CbGpPWpGaD
Sildenafil—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.64e-05	0.00182	CbGpPWpGaD
Sildenafil—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.63e-05	0.00181	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	3.61e-05	0.0018	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	3.6e-05	0.00179	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.58e-05	0.00178	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	3.58e-05	0.00178	CbGpPWpGaD
Sildenafil—CYP1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.49e-05	0.00174	CbGpPWpGaD
Sildenafil—CYP1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.44e-05	0.00172	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.43e-05	0.00171	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.33e-05	0.00166	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.29e-05	0.00164	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CST3—amyotrophic lateral sclerosis	3.25e-05	0.00162	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—CHAT—amyotrophic lateral sclerosis	3.23e-05	0.00161	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.22e-05	0.0016	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	3.15e-05	0.00157	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	3.13e-05	0.00156	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	3.07e-05	0.00153	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.07e-05	0.00153	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—SOD1—amyotrophic lateral sclerosis	3.04e-05	0.00151	CbGpPWpGaD
Sildenafil—PDE6G—Disease—APOE—amyotrophic lateral sclerosis	2.9e-05	0.00145	CbGpPWpGaD
Sildenafil—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.86e-05	0.00142	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.84e-05	0.00141	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.84e-05	0.00141	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	2.83e-05	0.00141	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	2.83e-05	0.00141	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	2.83e-05	0.00141	CbGpPWpGaD
Sildenafil—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.82e-05	0.0014	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.82e-05	0.0014	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	2.73e-05	0.00136	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.69e-05	0.00134	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.67e-05	0.00133	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.67e-05	0.00133	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.65e-05	0.00132	CbGpPWpGaD
Sildenafil—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.63e-05	0.00131	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.63e-05	0.00131	CbGpPWpGaD
Sildenafil—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.6e-05	0.0013	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.59e-05	0.00129	CbGpPWpGaD
Sildenafil—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.59e-05	0.00129	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	2.59e-05	0.00129	CbGpPWpGaD
Sildenafil—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.57e-05	0.00128	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	2.57e-05	0.00128	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.51e-05	0.00125	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.49e-05	0.00124	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.47e-05	0.00123	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.46e-05	0.00122	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.45e-05	0.00122	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.43e-05	0.00121	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.41e-05	0.0012	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.41e-05	0.0012	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—TP53—amyotrophic lateral sclerosis	2.38e-05	0.00119	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CASP9—amyotrophic lateral sclerosis	2.37e-05	0.00118	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.35e-05	0.00117	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.27e-05	0.00113	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.27e-05	0.00113	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	2.26e-05	0.00113	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	2.19e-05	0.00109	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	2.19e-05	0.00109	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	2.18e-05	0.00109	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.18e-05	0.00109	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.16e-05	0.00108	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	2.15e-05	0.00107	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.14e-05	0.00107	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.13e-05	0.00106	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	2.05e-05	0.00102	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	2.05e-05	0.00102	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.04e-05	0.00102	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.03e-05	0.00101	CbGpPWpGaD
Sildenafil—ABCC5—Disease—ERBB4—amyotrophic lateral sclerosis	2.02e-05	0.00101	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.01e-05	0.001	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.01e-05	0.001	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	2e-05	0.000997	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2e-05	0.000994	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2e-05	0.000994	CbGpPWpGaD
Sildenafil—PDE6G—Disease—PTGS2—amyotrophic lateral sclerosis	1.99e-05	0.00099	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	1.98e-05	0.000987	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	1.93e-05	0.000964	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.86e-05	0.000927	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.86e-05	0.000927	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.85e-05	0.000923	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	1.84e-05	0.000917	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	1.83e-05	0.000909	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.78e-05	0.000889	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.75e-05	0.000872	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.74e-05	0.000865	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.74e-05	0.000864	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.72e-05	0.000856	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.71e-05	0.000853	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.7e-05	0.000846	CbGpPWpGaD
Sildenafil—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.69e-05	0.000844	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.68e-05	0.000836	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	1.63e-05	0.00081	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.61e-05	0.000802	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.6e-05	0.000795	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.59e-05	0.000794	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.58e-05	0.000788	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.58e-05	0.000785	CbGpPWpGaD
Sildenafil—ABCC5—Disease—APOE—amyotrophic lateral sclerosis	1.57e-05	0.00078	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.55e-05	0.000774	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	1.55e-05	0.000773	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.47e-05	0.00073	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.47e-05	0.00073	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.46e-05	0.000725	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.44e-05	0.000719	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	1.43e-05	0.000715	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	1.43e-05	0.000713	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.37e-05	0.000685	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.35e-05	0.000674	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.32e-05	0.000656	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.32e-05	0.000656	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—APOE—amyotrophic lateral sclerosis	1.31e-05	0.000654	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.31e-05	0.000652	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.29e-05	0.000644	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.23e-05	0.000614	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.22e-05	0.000608	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.21e-05	0.000603	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.2e-05	0.0006	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.2e-05	0.000598	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.18e-05	0.000587	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	1.18e-05	0.000586	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.12e-05	0.000558	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.12e-05	0.000558	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.11e-05	0.000553	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.11e-05	0.000551	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.1e-05	0.00055	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.1e-05	0.000546	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.09e-05	0.000545	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PTGS2—amyotrophic lateral sclerosis	1.07e-05	0.000535	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.05e-05	0.000525	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.05e-05	0.000524	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.02e-05	0.000507	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.01e-05	0.000505	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.01e-05	0.000503	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.01e-05	0.000502	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	9.52e-06	0.000474	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.31e-06	0.000464	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.19e-06	0.000458	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TP53—amyotrophic lateral sclerosis	9.15e-06	0.000456	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	9.09e-06	0.000453	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.99e-06	0.000448	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.74e-06	0.000436	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.67e-06	0.000432	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	8.36e-06	0.000417	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.29e-06	0.000413	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	8.29e-06	0.000413	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.28e-06	0.000413	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.03e-06	0.0004	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.56e-06	0.000377	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	7.21e-06	0.000359	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.16e-06	0.000357	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.94e-06	0.000346	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	6.66e-06	0.000332	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	6.61e-06	0.000329	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.33e-06	0.000315	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.32e-06	0.000315	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.97e-06	0.000297	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.82e-06	0.00029	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.81e-06	0.000289	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.68e-06	0.000283	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.52e-06	0.000275	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.49e-06	0.000273	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	5.47e-06	0.000272	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.21e-06	0.00026	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.18e-06	0.000258	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.89e-06	0.000243	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	4.79e-06	0.000239	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	4.78e-06	0.000238	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.68e-06	0.000233	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.53e-06	0.000226	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	4.51e-06	0.000225	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.49e-06	0.000224	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.49e-06	0.000224	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.45e-06	0.000222	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.13e-06	0.000206	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.09e-06	0.000204	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.69e-06	0.000184	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.54e-06	0.000176	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	3.4e-06	0.000169	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	3.37e-06	0.000168	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.28e-06	0.000163	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.27e-06	0.000163	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.09e-06	0.000154	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.94e-06	0.000146	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.7e-06	0.000134	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.53e-06	0.000126	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.33e-06	0.000116	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.31e-06	0.000115	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.22e-06	0.000111	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.52e-06	7.58e-05	CbGpPWpGaD
